Pondicherry Journal of Nursing

Register      Login

VOLUME 13 , ISSUE 4 ( October-December, 2020 ) > List of Articles


Idiopathic Fatal Pancytopenia: A Case Report

Helen Shaji John Cecily, Retnam Golda Sahayarani

Citation Information : Cecily HS, Sahayarani RG. Idiopathic Fatal Pancytopenia: A Case Report. 2020; 13 (4):86-88.

DOI: 10.5005/jp-journals-10084-12161

License: CC BY-NC 4.0

Published Online: 01-03-2021

Copyright Statement:  Copyright © 2020; The Author(s).


Idiopathic fatal pancytopenia is a rare disease with a grave prognosis. Pancytopenia is defined as reduction in all three types of blood cells, such as erythrocytes, leukocytes, and thrombocytes. Erythrocytes transport oxygen to parts of our body; leukocytes play a major role in our body by fighting against infection and destroying pathogens; thrombocytes act as primary agents to stop bleeding at the site of injury. Pancytopenia predisposes to increase the chances of infection and bleeding tendencies.1–3 A 41-year-old female client got admitted in a hospital with the signs and symptoms of giddiness, bleeding per vagina for 20 days, breathlessness on exertion, generalized body weakness, vomiting, and pain abdomen. There were no abnormal findings on physical and systemic examination. Complete blood count (CBC) findings showed decreased number of all three kinds of cells, whereas other hematological parameters were normal. Stool examination revealed presence of occult blood with no abnormal findings on ultrasonography (USG). On bone marrow examination, hypercellular bone marrow was seen with reduction of all three blood cells. Patient was admitted in hospital for 20 days. The cause of pancytopenia remained unexplained. Following administration of blood and blood products, inotropes and hematinic therapy led to the recovery of the blood cell components to normal level. Bone marrow examination later became normal. Idiopathic fatal pancytopenia is a rare condition based on clinical and pathological features.

  1. Javalgi AP, Dombale VD. Clinico-hematological analysis of pancytopenia: a bone marrow study. National J Lab Med 2013;2(4):12–17. DOI: NJLM/2013/6782:1995.
  2. Manzoor F, Karandikar MN, Nimbargi RC. Pancytopenia: a clinico-hematologic study. Med J Dr DY Patil University 7(1):25–28. DOI: 10.4103/0975-2870.122763.
  3. Sandhya V. Bone marrow pathology in pancytopenia. Int J Sci Res 2016;5(5):323–325. ISSN No. 2277-8179, IF: 3.508, IC Value: 69.48.
  4. Negotia P, Saxena RS, Jagat RS, Dubey TN. Clinical etiological evaluation of pancytopenia. Int J Med Res Rev 2017;5(11):927–932. DOI: 10.17511/ijmrr.2017.i11.02. Print ISSN: 2321-127X, Online ISSN: 2320-8686.
  5. Tekwani D, Bawa S, Joshi R, Joshi SR. Clinico-haematological analysis of pancytopenia in adults. J Med Sci Clin Res 2017;5(3):19020–19026. DOI: 10.18535/jmscr/v5i3.115.
  6. Madhuchanda K. Pancytopenia. J Indian Acad Clin Med 2002;3(1):29–34.
  7. Jha A, Sayami G, Adhikari RC, Panta AD, Jha R. Bone marrow examination in cases of pancytopenia. J Nepal Med Assoc 2008;47(169):12–17. DOI: 10.31729/jnma.209.
  8. Pathak R, Jha A, Sayami G. Evaluation of bone marrow in patients with pancytopenia. J Pathol Nepal 2012;2(4):265–271. DOI: 10.3126/jpn.v2i4.6875.
  9. Khodke K, Marwah S, Buxi G, Vadav RB, Chaturvedi NK. Bone marrow examination in cases of pancytopenia. J Academy Clin Med 2001;2(1):55–59.
  10. Santra G, Das BK. A cross-sectional study of the clinical profile and aetiological spectrum of pancytopenia in a tertiary care center. Singapore Med J 2010;51(10):806–812.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.